Cargando…
Reappraisal of nodal Epstein‐Barr Virus‐negative cytotoxic T‐cell lymphoma: Identification of indolent CD5(+) diseases
Nodal cytotoxic molecule (CM)‐positive peripheral T‐cell lymphoma (CTL) has recently been recognized as a clinicopathologically distinct disease. To further characterize this disease, here we compared 58 patients with Epstein‐Barr virus (EBV)‐negative CTL to 48 patients with EBV‐positive CTL. The tw...
Autores principales: | Yamashita, Daisuke, Shimada, Kazuyuki, Takata, Katsuyoshi, Miyata‐Takata, Tomoko, Kohno, Kei, Satou, Akira, Sakakibara, Ayako, Nakamura, Shigeo, Asano, Naoko, Kato, Seiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113510/ https://www.ncbi.nlm.nih.gov/pubmed/29845715 http://dx.doi.org/10.1111/cas.13652 |
Ejemplares similares
-
PD‐L1 expression on tumor or stromal cells of nodal cytotoxic T‐cell lymphoma: A clinicopathological study of 50 cases
por: Yamashita, Daisuke, et al.
Publicado: (2020) -
Clinicopathological analysis of primary intestinal diffuse large B‐cell lymphoma: Prognostic evaluation of CD5, PD‐L1, and Epstein‐Barr virus on tumor cells
por: Ishikawa, Eri, et al.
Publicado: (2018) -
Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review
por: Sakakibara, Ayako, et al.
Publicado: (2021) -
Frequent downregulation of BTB and CNC homology 2 expression in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma
por: Noujima‐Harada, Mai, et al.
Publicado: (2017) -
A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas
por: Ando, Midori, et al.
Publicado: (2013)